ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Endometrial Cancer
Breast Cancer

Prostate Cancer trials near Nashville, TN, USA:

WATER IV Prostate Cancer (WATER IV PCa)

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Enrolling
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Nashville, Tennessee, United States and 38 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Nashville, Tennessee, United States and 18 other locations

Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (...

Enrolling
Prostate Cancer (Adenocarcinoma)
Prostate Cancer Metastatic Disease
Drug: HLD-0915

Phase 1, Phase 2

Halda Therapeutics OpCo, Inc.

Nashville, Tennessee, United States and 4 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Nashville, Tennessee, United States and 23 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

Nashville, Tennessee, United States and 22 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Not yet enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Nashville, Tennessee, United States and 145 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Nashville, Tennessee, United States and 54 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Nashville, Tennessee, United States and 31 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Placebo
Drug: Prednisone

Phase 2, Phase 3

Lilly
Lilly

Nashville, Tennessee, United States and 112 other locations

The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or sec...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Cabazitaxel
Drug: Enzalutamide

Phase 3

Amgen
Amgen

Nashville, Tennessee, United States and 99 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems